QT
GTHX

Quantamental Technologies’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quantamental Technologies’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,600
Closed -$59K – 1420
2019
Q3 		$59K Buy
+2,600
New +$82K 0.02% 921

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Quantamental Technologies's GTHX Position: Q4 2019 in Review

Quantamental Technologies sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2019, closing a stake of 2,600 shares — an estimated $59K sold.

Quantamental Technologies first reported a position in GTHX in Q3 2019 and held it in 1 quarter. The position peaked at $59K in Q3 2019. 98 funds tracked by Wall St. Rank hold GTHX as of Q4 2019.

  • Quantamental Technologies reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 2,600 G1 Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $59K.
  • Quantamental Technologies first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Quantamental Technologies's G1 Therapeutics, Inc. Common Stock position peaked at $59K in Q3 2019.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.